These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3300178)

  • 21. Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo.
    Olivieri D; Zavattini G; Tomasini G; Daniotti S; Bonsignore G; Ferrara G; Carnimeo N; Chianese R; Catena E; Marcatili S
    Respiration; 1987; 51 Suppl 1():42-51. PubMed ID: 3299567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial.
    Uzun S; Djamin RS; Kluytmans JA; Mulder PG; van't Veer NE; Ermens AA; Pelle AJ; Hoogsteden HC; Aerts JG; van der Eerden MM
    Lancet Respir Med; 2014 May; 2(5):361-8. PubMed ID: 24746000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations.
    Seemungal TA; Wilkinson TM; Hurst JR; Perera WR; Sapsford RJ; Wedzicha JA
    Am J Respir Crit Care Med; 2008 Dec; 178(11):1139-47. PubMed ID: 18723437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial.
    Ericsson CD; Johnson PC; Dupont HL; Morgan DR; Bitsura JA; de la Cabada FJ
    Ann Intern Med; 1987 Feb; 106(2):216-20. PubMed ID: 3541724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.
    Martinez FJ; Calverley PM; Goehring UM; Brose M; Fabbri LM; Rabe KF
    Lancet; 2015 Mar; 385(9971):857-66. PubMed ID: 25684586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials.
    Grandjean EM; Berthet P; Ruffmann R; Leuenberger P
    Clin Ther; 2000 Feb; 22(2):209-21. PubMed ID: 10743980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD--the ABACOPD study.
    Rohde GG; Koch A; Welte T;
    BMC Pulm Med; 2015 Jan; 15():5. PubMed ID: 25623589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.
    Brusasco V; Hodder R; Miravitlles M; Korducki L; Towse L; Kesten S
    Thorax; 2003 May; 58(5):399-404. PubMed ID: 12728159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Standard versus newer antibacterial agents in the treatment of severe acute exacerbation of chronic obstructive pulmonary disease: a randomized trial of trimethoprim-sulfamethoxazole versus ciprofloxacin.
    Nouira S; Marghli S; Besbes L; Boukef R; Daami M; Nciri N; Elatrous S; Abroug F
    Clin Infect Dis; 2010 Jul; 51(2):143-9. PubMed ID: 20536364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.
    Maltais F; Ostinelli J; Bourbeau J; Tonnel AB; Jacquemet N; Haddon J; Rouleau M; Boukhana M; Martinot JB; Duroux P
    Am J Respir Crit Care Med; 2002 Mar; 165(5):698-703. PubMed ID: 11874817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial.
    Stamm WE; Counts GW; Wagner KF; Martin D; Gregory D; McKevitt M; Turck M; Holmes KK
    Ann Intern Med; 1980 Jun; 92(6):770-5. PubMed ID: 6992677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of brodimoprim and doxycycline in acute respiratory tract infections. A double-blind clinical trial.
    Salmi HA; Lehtomäki K; Kylmämaa T
    Drugs Exp Clin Res; 1986; 12(4):349-53. PubMed ID: 3522157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of acute exacerbations of chronic bronchitis. A double-blind trial of cotrimoxazole and cephalexin.
    Cooper J; McGillion FB
    Practitioner; 1978 Sep; 221(1323):428-32. PubMed ID: 366597
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial.
    Allegra L; Cordaro CI; Grassi C
    Respiration; 1996; 63(3):174-80. PubMed ID: 8739489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.
    Paggiaro PL; Dahle R; Bakran I; Frith L; Hollingworth K; Efthimiou J
    Lancet; 1998 Mar; 351(9105):773-80. PubMed ID: 9519948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multi-centre trial comparing a sulfamethopyrazine/trimethoprim combination with co-trimoxazole in respiratory tract infections.
    Colombo ML; Peona V; Ginesu F; Ortu AR; Bagnato A; Dei D; Colombo F; Donno L
    Pharmatherapeutica; 1984; 3(8):556-65. PubMed ID: 6366810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease.
    Pavord ID; Chanez P; Criner GJ; Kerstjens HAM; Korn S; Lugogo N; Martinot JB; Sagara H; Albers FC; Bradford ES; Harris SS; Mayer B; Rubin DB; Yancey SW; Sciurba FC
    N Engl J Med; 2017 Oct; 377(17):1613-1629. PubMed ID: 28893134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Empirical treatment of Shigella dysentery with trimethoprim: five-day course vs. single dose.
    Oldfield EC; Bourgeois AL; Omar AK; Pazzaglia GL
    Am J Trop Med Hyg; 1987 Nov; 37(3):616-23. PubMed ID: 3688315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease.
    Russo RL; D'Aprile M
    Ann Pharmacother; 2001 May; 35(5):576-81. PubMed ID: 11346065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A post hoc pooled analysis of exacerbations among US participants in randomized controlled trials of tiotropium.
    Anzueto A; Niewoehner DE; Leimer I; Rühmkorf F; Celli BR; Decramer M; Tashkin DP
    Respir Med; 2013 Dec; 107(12):1912-22. PubMed ID: 23969305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.